1. Home
  2. Browse
  3. National Institutes of Health
  4. PAR-25-325

PAR-25-325National Institutes of HealthU01

Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)

Deadline
Award ceiling
Not stated
Awards
Not stated
Posted
Dec 13, 2024

Official announcement on the NIH Guide · opens the funder's page. Always confirm dates there.

Or read the full text and all 3 review criteria here, free with an account. Create free account

Summary

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to support extramural research to investigate and mitigate challenges facing clinical assay development and subsequent analytical validation due to preanalytical variability in tumor tissue biopsies, blood biospecimens utilized as liquid…

Related NIH announcements2

Other open U01 announcements on related subjects, with at least two weeks to go.

Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)

PAR-25-248National Institutes of Health3 review criteria on file

—

Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)

RFA-CA-27-019National Institutes of Health4 review criteria on file

$300k

The full announcement, free with an account

  • The full announcement text, not just the first two sentences
  • All 3 review criteria reviewers score this against, extracted from this announcement

On Plus, $39 a month

  • The eligibility check against your profile: career stage, institution type, and the windows that close before the deadline does
  • Funded precedents: what similar NIH projects received, from the award records in NIH RePORTER
  • A Reviewer Scorecard of your draft against these criteria
Create free accountSign in

No card required. Browsing is free.

Subjects

More from National Institutes of Health

Open now with at least two weeks to apply, soonest deadline first.

Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)

RFA-DK-27-139National Institutes of Health

—

NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

PAR-25-188National Institutes of Health3 review criteria on file

$500k

Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)

RFA-DK-27-112National Institutes of Health

—

Continuation or Revision of NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UH3 Clinical Trial Required)

PAR-25-062National Institutes of Health6 review criteria on file

—

Everything open from National Institutes of Health

Related by subject

Open opportunities sharing the most subjects with this one (Cancer), with at least two weeks to apply.

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

RFA-CA-27-002National Institutes of Health4 review criteria on fileagency framework

$300k

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

RFA-CA-27-001National Institutes of Health4 review criteria on file

$150k

Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Not Allowed)

PAR-27-025National Institutes of Health7 review criteria on fileagency framework

—

Everything open tagged Cancer

Hiring in this research area now

All oncology jobs

Source record: https://grants.nih.gov/grants/guide/pa-files/PAR-25-325.htmlVia the NIH Guide. Last checked against the source . Always confirm dates with the funder.